ProQR Therapeutics N.V

PRQRNASDAQ · USD
1.66USD0.00 (+0.61%)
135

ProQR Therapeutics N.V (PRQR) Unusual Options Activity Today

PRQR options volume power reached 2.5x on the previous trading day. The highest reading was on the $5 CALL expiring 2027-04-16.

Read more

Checking PRQR unusual options activity helps you spot when traders are making outsized bets on ProQR Therapeutics N.V before the broader market catches on. ProQR Therapeutics N.V's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor PRQR unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching PRQR unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking PRQR unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and PRQR unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system.

ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

Catalysts rarely arrive without a footprint, and PRQR unusual options activity is often where that footprint shows up first. Our scanner tracks ProQR Therapeutics N.V's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at PRQR unusual options volume on the call side or chasing put sweeps, ProQR Therapeutics N.V's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
1.50—0.550.55364%43112.90%
2.50—0.100.10226%61,4540.41%
5.00—0.200.20498%21,2800.16%
0.500.701.701.20458%00—
1.000.051.050.5521%010.00%
Puts
0.50—1.001.001,000%00—
1.00—0.100.10313%00—
1.50—0.200.20211%00—
2.000.051.050.55239%00—
2.50—0.900.90193%010.00%

As of September 30, 2026

Spot unusual options activity before it moves

Track PRQR options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial